Indivumed collects and processes solid tumor tissue across all cancer types using our ISO-certified standardized protocol. This innovative and market-leading approach enables research with comparably-processed tissues regardless of whether they are derived from different tumor entities, different patients, or different clinics on the globe.

Together with extremely short ischemia times and standardized sample preparation, we ensure the best quality and, subsequently, the best research data. Our customers benefit from outstanding expertise in tissue collection (together with clinical data procurement), tissue processing, and tissue qualification, performed by our dedicated in-house pathology and data management team. All actions follow the Indivumed Standard Operating Procedure, which adheres to stringent processes to collect and preserve biospecimen. This generates samples that retain patterns of biomolecules such as RNA, DNA, and protein as closely comparable to their state when in the human body as possible. All Indivumed biobanking procedures follow strict ethical standards.

The resulting biospecimen products and clinical data sets cover the complete range of client needs.

Indivumed biospecimen are obtained with full and informed consent from participating patients within the Indivumed clinical network. Immediately after surgical excision, highly trained study nurses present in the operating room accurately document intra- and postsurgery ischemia times and preserve tissues in most patients in under 10 minutes according to Indivumed’s ISO-certified standard operating procedure, thus ensuring the highest quality biological sample.


Types of biospecimen:

Tissue (Fresh-frozen/FFPE)

  • Tumor center
  • Tumor periphery
  • Matched normal



  • Plasma (1 mL)
  • Serum (0.5 mL)
  • PBMCs (aliquot 0.05 mL)

Urine (0.5 or 9.0 mL)

  • Supernatant
  • Sediment

Related Content